| Lacinda Marie Rishel, PA-C | |
|
1350 Flemingsburg Rd, Morehead, KY 40351-1810 | |
| (606) 462-8016 | |
| (606) 462-8046 |
| Full Name | Lacinda Marie Rishel |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 14 Years |
| Location | 1350 Flemingsburg Rd, Morehead, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619286739 | NPI | - | NPPES |
| 7100328660 | Medicaid | KY | |
| PA1601 | Other | KY | KY MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | PA1601 (Kentucky) | Secondary |
| 363A00000X | Physician Assistant | PA1601 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bluegrass Orthopaedics Psc | 4789988981 | 50 |
News Archive
The Department of Health and Human Services has awarded more than $971 million to continue improving preparedness and health outcomes for a wide range of public health threats within every state, eight U.S. territories, and four of the nation's largest metropolitan areas.
China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company has finished the required research for two new generic drugs for eye treatment and submitted application to the State Food and Drug Administration (SFDA) in China to perform clinical trials.
The response of a patient with metastatic brain tumors to treatment with stereotactic radiosurgery in the first six-to-twelve weeks can indicate whether follow-up treatments and monitoring are necessary, according to research conducted at the University of North Carolina.
Feel like Mom is pushing dessert? According to a new study in the Journal of Consumer Research, consumers choose foods that are less healthy when they are purchasing for others.
Researchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of tucatinib to capecitabine (Xeloda) and trastuzumab (Herceptin) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with advanced HER2-positive breast cancer, with and without brain metastasis according to results of the HER2CLIMB clinical trial.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lacinda Marie Rishel, PA-C 3480 Yorkshire Medical Park, Lexington, KY 40509-1886 Ph: (859) 263-5140 | Lacinda Marie Rishel, PA-C 1350 Flemingsburg Rd, Morehead, KY 40351-1810 Ph: (606) 462-8016 |
News Archive
The Department of Health and Human Services has awarded more than $971 million to continue improving preparedness and health outcomes for a wide range of public health threats within every state, eight U.S. territories, and four of the nation's largest metropolitan areas.
China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company has finished the required research for two new generic drugs for eye treatment and submitted application to the State Food and Drug Administration (SFDA) in China to perform clinical trials.
The response of a patient with metastatic brain tumors to treatment with stereotactic radiosurgery in the first six-to-twelve weeks can indicate whether follow-up treatments and monitoring are necessary, according to research conducted at the University of North Carolina.
Feel like Mom is pushing dessert? According to a new study in the Journal of Consumer Research, consumers choose foods that are less healthy when they are purchasing for others.
Researchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of tucatinib to capecitabine (Xeloda) and trastuzumab (Herceptin) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with advanced HER2-positive breast cancer, with and without brain metastasis according to results of the HER2CLIMB clinical trial.
› Verified 5 days ago
Shane Travis Kiser, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 Fax: 606-783-7281 | |
Marsha Alfrey Dehaven, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 245 Flemingsburg Rd, Morehead, KY 40351 Phone: 606-780-5500 Fax: 606-783-7281 | |
Kyra Shae Baier, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1777 Us Highway 60 W Trlr 4, Morehead, KY 40351 Phone: 606-316-0428 | |
Caryn R Grim, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1350 Flemingsburg Rd, Morehead, KY 40351 Phone: 859-263-5140 Fax: 859-263-5141 | |
Bethany Mcclure, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2300 Ky 801 North, Morehead, KY 40351 Phone: 606-548-5550 | |
Kevin Scott Cummins, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 333 Beacon Hill Rd Ste 201, Morehead, KY 40351 Phone: 606-780-0444 | |
Ashley M Fay, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 222 Medical Cir, Morehead, KY 40351 Phone: 606-783-6500 |